Platinum-resistant Ovarian Cancer (PROC)

specific

A platinum-resistant ovarian carcinoma that has spread from its original site of growth to another anatomic site.

18

Centers

15

Active Trials

Cancer Funding

Top Centers for Platinum-resistant Ovarian Cancer (PROC)(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.8
2
NCI Comprehensive
High-Volume Research Center
72.8
3
NCI Comprehensive
Active Research Program
56.5
4
NCI Comprehensive
Active Research Program
56.5
5
NCI Comprehensive
Active Research Program
56.5
656.5
7
NCI Comprehensive
Active Research Program
56.5
8
NCI Comprehensive
Active Research Program
56.5
9
Active Research Program
56.5
10
NCI Comprehensive
Active Research Program
56.5
11
Active Research Program
56.5
12
Active Research Program
56.5
13
Active Research Program
56.5
14
NCI Comprehensive
36.5
15
Cedars-Sinai CancerLos Angeles, CA
36.5
16
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
36.5
1736.5
1836.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →